Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients
Recruiting · NCT07245134 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly assigned to one of the following interventions: a) exposure condition - the group with a standard CBT program enriched with exposure therapy in VR (VRET), b) control condition 1 - the group with a standard CBT program enriched with VR cognitive training aimed at cognitive flexibility or c) control condition 2 - standard CBT program without any additional VR intervention. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.
Who can take part
Inclusion criteria
- Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11
- Fluent in Czech
Exclusion criteria
- Any other psychiatric, neurological and serious somatic illness
- Substance abuse
- Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics.
- Contradictions to using a virtual reality (e.g., epilepsy, balance problems)
- Pregnancy
- Cardiostimulator and mental implants
Where it is running
1 location listed.
- National Institute of Mental Health - Klecany, Czechia